Why is vaccination against mastitis so difficult? by Werling, D
Focus
Many different bacterial species have the ability to 
cause a repeated infection of the bovine mammary 
gland and the host response to these infections is what 
is generally described as mastitis. In this article I will try 
to explain why the development of vaccines against 
mastitis-causing pathogens is so difficult. However, I 
will also provide insight into new developments 
regarding vaccination against two main bacterial species 
causing bovine mastitis: Escherichia coli and Staphylo-
coccus aureus. I will also describe that the host immune 
response differs significantly depending on the invading 
bacterial species, and that this may affect our ability to 
generate vaccines able to induce a long lasting memory. 
The relevance of fully understanding the bovine host 
response to intramammary infection is discussed, some 
major gaps in our knowledge are highlighted and direc-
tions for future research are indicated.
Text: Dirk Werling - Royal Veterinary College, Department of Pathology and Pathogen Biology - London, AL9 7TA - Dwerling@RVC.AC.UK 
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Our immune system consists of two arms: the innate immune system, 
the one we are born with, and the adaptive immune system, which 
develops over the years and shapes our fast response to re-occurring 
infections. The differences between these two arms are quite striking. 
Whereas the innate immune system is there from the beginning, and 
has as it’s main aim to destroy invading pathogens by a process called 
phagocytosis (or in other words: eat and digest everything foreign), it will 
never develop a memory and will respond every time in exactly the same 
way. In contrast, the adaptive immune system is the one which becomes 
more and more specific every time we encounter the same pathogen, 
leading to a very specialised, fast and extremely specific response. To 
obtain a co-ordinated adaptive immune response, cells of the adaptive 
immune-system (T- and B-cells) need to be appropriately stimulated. 
This normally requires the uptake of a pathogen by cells of the innate 
immune system, the professional antigen presenting cells (APC), such as 
dendritic cells (DC) and macrophages (MØ). These cells are spread out 
through the tissue, and recognise invading pathogens using specific 
receptors, such as TOLL-like receptors (TLRs) via pathogen-associated 
molecular pattern (PAMP) being expressed by the pathogen. PAMPS are 
in most cases glycolipids and glycoproteins being present in the wall 
of pathogens, and include substances such as lipoteichoic acid (LTA), 
peptidoglycan (PGN) and lipopolysaccharides (LPS). Binding of PAMPs 
to TLRs stimulates a signal into the cells, resulting in the generation of 
three main signals necessary to subsequently stimulate the adaptive 
immune response: 1) Upregulation of MHC class II molecules (presenting 
peptides derived from the pathogen to the T-cell receptor); 2) Upregula-
tion of co-stimulatory molecules helping to activate T-cells; and 3) secre-
tion of pro-inflammatory cytokines (driving the maturation of T-cells, 
and thus subsequently B-cells) (Werling and Jungi, 2003). Upon their 
stimulation, APC present within the mammary gland tissue (Maxymiv 
et al., 2012) migrate into the regional draining lymphnodes where the 
majority of T- and B-cell stimulation occurs, resulting in the generation 
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of an adaptive immune response. In the case of the bovine udder, these 
lymphnodes are the mammary (superficial inguinal) lymphnode, the 
subiliac (prefemoral) lymphnode, and the ischial lymphnode (Figure 1). 
However, despite the fact that all necessary requirements for developing 
a long-lasting immunity to mastitis-causing pathogens are present, the 
host on its own does not seem to be able to stimulate the induction of 
a long-lasting adaptive immune response. 
So, why does it not work?
Intramammary infections (IMI) in dairy cows are a major concern 
for the dairy industry. These infections lead to severe milk loss, are 
potentially fatal and are a major cost to dairy farmers. For this reason, 
there is an active research effort to understand the pathogenesis of 
mastitis, the inflammatory response to an intramammary infection, as 
well as the search for alternatives to antibiotic treatments. In the last 
decade our knowledge about the inflammatory response to infection 
has improved, both in terms of a better understanding of the mammalian 
immune response and the immune response of the bovine mammary 
gland (Rainard and Riollet, 2006). Similarly, biopsies of the mammary 
epithelium have revealed much about the regulation of genes involved 
in the host response to an IMI (Genini et al., 2011). The immune response 
pattern in the acute phase response was dominated by an up-regulation 
of chemokine and cytokine pathways, TLR signalling pathways and 
leukocyte transendothelial migration (Buitenhuis et al., 2011). The 
importance of the innate arm of the immune defence has been more 
fully appreciated with our increased understanding of the interaction 
of specific conserved PAMPs with TLRs.
However, important differences exist in the response to IMI caused by 
different bacterial species. Bacterial growth patterns and the associated 
innate immune response differ significantly between gram-negative 
bacteria such as Escherichia coli (E. coli) and gram-positive bacteria such 
as Streptococcus uberis (S. uberis). Infections caused by E. coli are more 
typically, but not exclusively, associated with a fast and more dramatic 
immune response, whereas infections with S. uberis are characterized 
by a delayed and less dramatic response (Bannerman, 2009; Genini 
et al., 2011; Rambeaud et al., 2003). In contrast, Staphylococcus aureus 
(S. aureus) appears to mostly circumvent the host immune response 
and IMI typically result in a very moderate host response with minimal 
observable innate immune response (Petzl et al., 2008). These pathogen-
specific responses can also be recognized in the somatic cell count 
patterns in milk relative to IMI, milk production losses and risks of culling 
and death.
A full understanding of the adaptive immunity in the context of 
mammary health provides challenges since the ruminant mammary gland 
is unique in that lymphocyte trafficking, which is essential to adaptive 
Subiliac (prefemoral)
lymph node
Ischial lymph
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Mammary (superficial inguinal)
lymph node
To deep inguinal
lymph node
Figure 1.
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immunity, is shared with the peripheral immune system rather than the 
common mucosal immune system (Figure 2). Protective immunity of the 
bovine mammary gland invoked by natural infection with bacterial organ-
isms has shown to be relatively short-lived. A partial protection against 
subsequent natural infection disappeared within weeks (Schukken et al., 
2009; Suojala et al., 2008). This relative inability to mount an adequate 
and long-lasting protective response to natural infection provides a 
major challenge for the development of effective vaccines to protect 
the bovine mammary gland from infection.
Pathogen – Evasion mechanisms
E. coli
Pathogenicity characteristics of gram-negative mastitis pathogens 
have been studied in recent years. It was shown that E. coli pathogens 
express a variety of virulence factors but no coherence between the 
severity of the disease and specific virulence factors could be defined 
(Bean et al., 2004; Suojala et al., 2008; Wenz et al., 2006). However, the 
ability to grow in mammary secretions and to liberate lipopolysaccharide 
(LPS) is crucial in the pathogenesis of mastitis caused by gram-negative 
bacteria. The faster bacterial numbers increase in the mammary gland, 
the more LPS is present in the mammary gland and the faster the inflam-
matory response and clinical disease may occur (Mehrzad et al., 2008). 
Gram-negative bacteria utilize milk nutrients to grow and multiply. A 
clear advantage for the gram-negative bacteria is the utilization of 
lactose as an energy source from milk, and a causal mechanism for the 
relationship between initial bacterial numbers and subsequent immune 
response was recently identified by demonstrating that the extent of 
induced cytokine synthesis (TNF-α, IL-8) in mammary epithelial cells 
(MEC) positively correlated with the concentration of E. coli particles 
(Gunther et al., 2010). 
The implication of the body-udder barrier and the 
barrier between the two udder-halves:
1. acquired immunity in the body is only partial and at 
a lower level in the udder
2. not all the immune responses in the mammary 
glands will be recognized by the body
Systemic immunity
Macrophage + bacteria
supra-mammary
lymph node
Local immunity
Figure 2.
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S. aureus
S. aureus is an important cause of IMI in dairy cows. It is commonly 
assumed that most IMI are the result of cow-to-cow transmission where 
other infected animals in the herd are the source of the organism. 
However, other sources of S. aureus bacteria in the environment of a 
dairy cow have been described and in many herds a dominant, presum-
ably contagious strain of S. aureus co-exists with a large collection of 
other, presumably non-contagious strains (Zadoks et al., 2002). Both in 
experimentally infected cows and in cows sampled longitudinally with 
a naturally occurring S. aureus IMI, a low and high shedding cycle were 
observed. Similar to E. coli, S. aureus has developed a variety of escape 
mechanisms to evade immune recognition (Garzoni and Kelley, 2009), 
and these occur on all levels of the host-cell, potentially leading to a 
persistent infection of the cell (Loffler et al., 2014). Indeed, persistent 
intramammary infections are an important component of the problem in 
bovine mastitis. Clinical mastitis with possible life-threatening severity 
is of importance to the cow and the dairy farmer, however the presence 
of persistent intramammary infections causing long-term increases in 
somatic cell counts and repeated clinical cases form another major 
concern to dairy producers. Persistent infections are very common for 
gram-positive organisms such as Streptococcus agalactiae, S. aureus, 
CNS and Corynebacterium bovis; are common for gram-positive patho-
gens such as S. uberis and Streptococcus dysgalactiae and are not 
uncommon in gram-negative bacteria such as Serratia spp., Klebsiella 
spp. and have also been reported for E. coli IMI.
Vaccination against mastitis-causing bacteria
The immune response is often described as consisting of an innate 
and adaptive immune response arm. The adaptive immune system is 
the arm of the immune system that specifically responds to an antigen. 
Whereas the innate immune system uses either passive barriers or 
receptors that recognize conserved microbial molecules. The innate 
defence mechanisms of the mammary gland include physical barriers 
such as the teat sphincter, chemical barriers such as teat canal keratin 
and lactoferrin, and more proper components of the immune system such 
as macrophages, dendritic cells, mast cells, neutrophils, eosinophils and 
natural killer (NK) cells The importance of the innate immune response 
in the udder, and the mechanisms involved, have been nicely discussed 
recently (Schukken et al., 2011).
In addition to all aspects of the innate response, milk in healthy cows 
has a resident population of immune cells. This population is generally 
dominated by macrophages but also contains neutrophils and lympho-
cytes (Sordillo, 2005). Lymphocytes are divided into two main groups: 
T and B lymphocytes. The T lymphocytes can be classified further into 
αβ T lymphocytes, which include CD4+ (T helper) and CD8+ (T cyto-
toxic) lymphocytes, and γδ T cells. In the lactating mammary glands, 
αβ T lymphocytes prevail and predominantly express the CD8+ pheno-
type (Shafer-Weaver et al., 1996; Shafer-Weaver and Sordillo, 1996). The 
function of activated cytotoxic T cells (CD8+) is to kill host cells infected 
with a pathogen, as detected by antigens expressed on the surface of 
infected cells. Helper T cells (CD4+) have a more indirect but equally 
important effect on the infection. When a T
H
 cell matures, it develops 
into one of four types of T
H
 cells. Stimulation of these mature T
H
 cells 
can cause the expression a large variety of cytokines that can direct the 
immune response toward a pro-inflammatory cytotoxic T cell-mediated 
(T
H
1), B-cell-mediated (T
H
2), neutrophil-mediated response (T
H
17), or 
to counter-regulate the response (T
reg
). During bacterial infection of the 
bovine mammary gland, large numbers of leukocytes migrate into the 
udder, resulting in the establishment of a host response against the 
pathogen. Currently, the specific leukocyte populations mediating this 
immune response are not well defined. Cell surface markers are used to 
identify the specific cell populations identified in the mammary immune 
response. There is an increasing range of well-characterized monoclonal 
antibodies (mAbs) available for, and raised against, bovine cell surface 
markers. A list of bovine specific antibodies against cell surface markers 
is maintained by the US veterinary immune reagent network and is 
accessible at http://www.umass.edu/vetimm/ruminants/index.html.
The adaptive immune system can not only specifically recognize a 
species of microbe, but also distinguish variants of a species. Antibodies 
generated by B cells recognize whole antigens, whereas the T-cell 
receptors recognize fragments of antigens presented by specialized 
molecules called major histo-compatibility complex (MHC) class I or class 
II molecules.
E. coli vaccine
The adaptive immune response to IMI has mostly been studied in 
relationship to either E. coli or S. aureus IMI. Commercial vaccines are 
available for both these organisms, although the efficacy of the vaccines 
to protect against IMI with these two organisms is still debated. Vaccina-
tion with a core J5 E. coli vaccine is commonly practiced on dairy farms 
in the USA and commercial J5 vaccines are now also available in Europe. 
The J5 vaccine is assumed to be effective in reducing the severity of 
clinical mastitis (Gonzalez et al., 1989). Higher J5-specific IgG1 and 
IgG2 antibody are typically observed in J5 vaccinates after vaccination. 
A distinguishing feature of immunological memory is the irreversible B 
cell genetic change from IgM production to production of other antibody 
isotypes, including IgG1 and IgG2 (Burton et al., 2005). In the bovine 
as well as in several other species, an immune response with more 
production of IgG2 antibody has been recognized as part of a Th1 or 
pro-inflammatory response, while a response with more IgG1 is part of a 
Th2 or anti-inflammatory response (Stevens et al., 1988). Because IgG2 
is an important opsonizing antibody aiding in neutrophil phagocytosis 
of bacteria, and IgG2 has the ability to readily fix complement, it has 
been suggested that an IgG2 Th1-type response might be beneficial 
against bovine mastitis. Wilson et al (Wilson et al., 2007a, 2008; Wilson 
et al., 2007b, 2009) provided evidence that increased production of 
both J5-specific IgG1 and IgG2 antibodies are important mechanisms 
of J5 vaccine protection, including the production of a higher proportion 
of IgG2 than in non-vaccinates, a Th1 biased response. Serum ratio of 
J5-specific IgG1:IgG2 was reported to be less than one in vaccinates 
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post-calving, thus demonstrating a Th1 biased response after calving. 
Immunological memory stimulated by J5 vaccination is generally asso-
ciated with lower bacterial growth after IMI, a reduced milk production 
loss and lower cull rates following clinical mastitis compared to unvac-
cinated controls. These benefits decrease on a continuous basis as the 
lactation progresses, with a waning of vaccine protection over time. 
This raises the question of the optimum J5 immunization schedule for 
producing long-lasting immunological memory associated with sero-
conversion to long-lasting high titers of anti-J5 antibody. Based on a 
study in steers, the authors suggested that a large number of doses of J5 
bacterin may be needed to obtain a high concentration of IgG2 reactive 
against J5 (Chaiyotwittayakun et al., 2004).
S. aureus vaccines
A number of studies have been published on antibody-driven vacci-
nation to prevent staphylococcal (predominantly S. aureus) IMI. Very 
extensive studies were performed by colleagues in Israel. Leitner et 
al described a field study of a S. aureus vaccine (Leitner et al., 2003a; 
Leitner et al., 2003b; Leitner et al., 2003c). A total of 452 Holstein 
heifers were included in the trial with 228 heifers being vaccinated and 
224 serving as unvaccinated controls. Antibody response was detected 
in all vaccinated animals 4-5 weeks post-primary immunization and it 
was sustained for approximately 300 days. No significant difference 
in S. aureus infections was observed, in the vaccinated group 1.3% 
of heifers became infected and this was 2.7% in the control group. 
Middleton et al (Middleton et al., 2006) performed a challenge study 
in vaccinated and control heifers. All heifers were challenged with a 
heterologous strain of S. aureus by intramammary infusion on days 6-8 
of lactation in a single infection-free mammary quarter. All cattle became 
infected with S. aureus after challenge and there were no differences in 
S. aureus clearance rates between groups. Vaccinated heifers did show a 
lower mean duration of clinical mastitis and a lower total mastitis score 
post-challenge than controls. More recently, Prenafeta et al evaluated a 
S. aureus vaccine based on an extracellular slime associated antigenic 
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complex from S. aureus (Prenafeta et al., 2010). Twelve animals were 
vaccinated at 45 days before the expected parturition date and revac-
cinated 35 days later. All cows were challenged with a heterologous 
strain of S. aureus 23 days after calving. Immunization enhanced anti-
body titers against the slime-associated complex. However, there was 
no evidence of a difference between vaccinated and control groups 
with regard to IMI and clinical signs of mastitis following the challenge. 
Vaccinated cows showed a reduced S. aureus concentration in milk during 
the post-challenge period. More promising attempts involving PAMPs 
were recently made by Leitner et al who combined an S. aureus vaccine 
with an enhancer of phagocytosis, which enhanced clearance of bacteria 
(Leitner et al., 2013).
Combination vaccines
A very promising study was published this year using the Startvac 
vaccine (Hipra, Spain) (Schukken et al., 2014), which was introduced 
within the last few years in Europe. This vaccine combines the 
E. coli J5 strain and several S. aureus components (Harro et al., 2010; 
Prenafeta et al., 2010). Here, vaccination resulted in a moderate reduc-
tion of new IMI as well as a reduction in the duration of IMI caused 
by staphylococci. 
Discussion
Although much progress has been made in understanding the patho-
biology of mastitis, there are still important areas that remain poorly 
understood. Among these important gaps in our knowledge are relation-
ship between intramammary infection, TLR-based immune response 
and the resulting cytokine profiles. The compromised up-regulation 
of inflammatory cytokines in S. aureus infected glands may, at least 
partially, contribute to the persistent course of infection caused by 
this pathogen. Further research on identifying factors responsible for 
the differentially expressed cytokine profiles may be fundamental to 
developing strategies that mitigate the outcome of bovine mastitis. 
There are circumstances where an apparent disconnect exists between 
IMI and an up-regulation of TLRs and subsequent cytokine production. 
The molecular causes for this delay are currently unknown. Once they 
are unravelled, then these might possibly offer new molecular targets 
for improved therapy of persistent S. aureus infections. A better under-
standing of differences in host immune response to different bacterial 
pathogens may provide opportunities for up or down regulating of the 
immune responsiveness. 
There is currently a very shallow insight in the cell-mediated immunity 
as it pertains to mastitis. It is unclear how the cell-mediated immunity 
cascades after an IMI and whether pathogen specific and lactation 
stage specific patterns exist. Preliminary evidence would suggest that 
during late gestation, the cell-mediated immunity is biased toward a 
T
H
2 dominance changing the dominant direction of protection against 
invading bacteria. Furthermore, the pathogen-specific importance of 
the cell-mediated immunity is suspected, with a suggested role for 
lymphocytes in the acquired protection against S. uberis IMI (Hill, 1988) 
To better understand the pathogenesis of mastitis and increase our 
ability to modify immune responsiveness, future research into cell-
mediated immunity in mastitis is warranted.
An ability to modify the immune response to an IMI will likely provide 
therapeutic opportunities to either up or down-regulate the immune 
response depending on the clinical condition of the patient. Further 
genomic and proteomic research on the impact of calving and the start 
of lactation on transcription of the host genome will provide insight in 
the underlying reasons for immuno-suppression in the peri-parturient 
period. These findings support a holistic approach to the study of 
the bovine immune response. These studies would include genetics 
but also physiological status of the animal. The recent completion 
and release into the scientific community of the bovine genome 
(http://www.ncbi.nlm.nih.gov/projects/genome/guide/cow/), provides 
a unique opportunity to better understand the underlying biological 
reasons for improved udder health. 
M
2
-m
a
g
a
z
in
e
 |
 #
 9
 |
 2
0
1
4
 |
 J
U
N
E
|
23
Focus
Finally, our lack of highly efficacious intervention tools to support the 
immune response of mastitis affected cows, contributes to pain and 
suffering in these animals. Further research into the value of immune-
altering, symptomatic and antimicrobial therapy is warranted, certainly 
with regard to newly recognized elements such as pain control and milk 
production losses. Similarly, prevention of IMI and subsequent clinical 
mastitis through a next generation of vaccines will provide more long-
term solutions to the increasing problem of mastitis in dairy cows.
Outlook
Whereas the studies described in this article clearly indicate that 
vaccination against mastitis-causing pathogens will become more and 
more advanced within the next years, it also raised several semantic 
issues, which may impact on our understanding on an efficient vaccine. 
Indeed, different groups within the process of developing new vaccines 
may have completely different definitions when thinking about mastitis 
and the term “efficient vaccine”. These definitions may vary from “free of 
any inflammation markers” in terms of mastitis to “SCC is back in normal 
range”, or “induction of sterile immunity” to “reduction of severity of 
clinical signs by XY per cent” in the case of vaccines. It will become more 
and more important over the next years, that all parties involved, farmers 
– practitioners – pharma-companies and veterinary scientists will become 
more aware of the different definitions each group is working with, and 
keep these in mind when talking to each other. And lastly, one has to 
keep in mind that vaccination may represent only one side of dealing 
with mastitis – other factors have to be taken into account as well and 
should not be neglected (Figure 3). 
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